Full-Time

Customer Operations Specialist 1

Updated on 8/23/2026

Integer Holdings Corporation

Integer Holdings Corporation

1,001-5,000 employees

Medical device CDMO for cardiac devices

No salary listed

Quakertown, PA, USA

In Person

Bachelor's

Category
Operations & Logistics (1)
Required Skills
Microsoft Office
FDA Regulations
SAP Products
Customer Service
Oracle

Get referred to Integer Holdings Corporation

See people who can refer or advise you

Requirements
  • A Bachelor's degree in business or a related field is required.
  • At least 2 years of experience in medical device or a related field is required.
  • Knowledge of sales and customer service principles is required.
  • The ability to communicate effectively across all organizational levels, both verbally and in writing, is required.
  • The ability to work independently and within a team is required.
  • The ability to stay organized and adaptable while meeting business deadlines in a dynamic environment is required.
  • The ability to manage multiple tasks simultaneously is required.
  • Strong problem-solving skills are required.
  • Strong computer skills, including Microsoft Office products, are required.
Responsibilities
  • Support customer service activities for internal and external customers by applying knowledge of site products, services, and local processes to customer requirements.
  • Execute routine order management and communication tasks, including standard and repeat quoting and order management for factory-direct customers.
  • Process customer orders, standard quotations, and order entry using defined procedures and tools.
  • Respond to routine customer inquiries and requests with guidance from others.
  • Partner with Customer Operations Specialists and cross-functional teams, including Sales, Planning, and Quality, to meet customer requirements.
  • Coordinate internally to support lead-time communication, expedite requests, and routine customer updates.
  • Execute timely and accurate transactions that contribute to Quote Cycle Time and Order Acknowledgement Cycle Time metrics.
  • Collect documents and data needed for audits, business reviews, or reporting under the guidance of a senior team member.
  • Help ensure item setup, pricing, and revisions related to customer requirements are documented and up to date.
  • Participate in continuous improvement activities by identifying process enhancements that improve accuracy and responsiveness.
  • Participate in customer visits or audits to observe and support customer engagement at the site level.
  • Perform other duties as assigned.
Desired Qualifications
  • Experience in medical device manufacturing is preferred.
  • Experience reading and understanding design drawings and specifications is preferred.
  • Experience with Oracle and/or SAP is a plus.
Integer Holdings Corporation

Integer Holdings Corporation

View

Integer Holdings Corporation is a large medical device contract development and manufacturing organization (CDMO) that supports medical device makers in cardiac rhythm management, neuromodulation, and cardiovascular markets. It provides end-to-end services from design support to manufacturing, delivering components and finished subsystems such as implants, housings, electrodes, and batteries through its Greatbatch Medical, Lake Region Medical, and Electrochem brands. The company differentiates itself by its scale, breadth of capabilities across multiple medical specialties, established brand portfolio, and global manufacturing footprint that enable reliable, integrated supply. Its goal is to improve patients’ lives worldwide by helping customers bring safe and effective medical technologies to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, Delaware

Founded

1940

Get referred to Integer Holdings Corporation

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 3, 2026 KKR deal prices Integer at $127, a 51.8% premium.
  • Second-quarter 2026 revenue hit $464.1 million and adjusted EPS reached $1.60.
  • KKR promised capacity, technology, and talent investment, plus employee ownership after closing.

What critics are saying

  • KKR closing slips past year-end 2026 if antitrust or stockholder votes fail.
  • Halper Sadeh's August 2026 investigation fuels litigation over fairness and disclosure.
  • New Ross shutdown exposed demand volatility and labor pain; repeat interruptions threaten margins and credibility.

What makes Integer Holdings Corporation unique

  • Integer's 2026 KKR sale confirms sticky device-manufacturing scale and regulatory know-how.
  • Its CDMO footprint serves interventional cardiology, neuromodulation, and orthopedics across global customers.
  • New Ross and other plants give Integer specialized capacity competitors cannot quickly replicate.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Adoption Assistance

Parental Leave

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 16th, 2026
Healthcare stocks outpace S&P 500 by 13 percentage points over six months

Healthcare stocks have returned 26.1% over the past six months, outperforming the S&P 500 by 13.1 percentage points. However, investors must remain cautious due to heavy regulation affecting earnings potential. Integer Holdings faces concerns with 6.1% annual revenue growth over two years, lagging healthcare peers. Its modest revenue base of $1.84 billion provides less fixed cost leverage than larger competitors. The company trades at $125.07 per share, or 18.6 times forward price-to-earnings. Evolent Health shows weak platform performance and declining returns on capital. Its high net-debt-to-EBITDA ratio of 7 times could force unfavourable capital raises if market conditions worsen. Shares trade at $4.15, representing 12.4 times forward price-to-earnings. Tenet Healthcare, operating hospitals and surgical centres across nine US states, emerges as the recommended healthcare investment.

Yahoo Finance
Aug 4th, 2026
Integer Holdings acquired by KKR for $5.7B in all-cash deal at $127 per share

Integer Holdings agreed to be acquired by private equity firm KKR in an all-cash deal valued at approximately $5.7 billion. The transaction values the medical technology company at $127 per share. Shares jumped 2.7% in afternoon trading, continuing a rally from the previous session when the stock surged over 20% following the announcement. The acquisition news overshadowed strong second-quarter results, where Integer posted an adjusted profit of $1.60 per share on $464.1 million in revenue, surpassing analyst estimates. Following the buyout announcement, Integer withdrew its previously issued financial guidance and cancelled its upcoming earnings conference call. Shares traded at $124.50, marking a new 52-week high.

BizWire Express
Aug 3rd, 2026
KKR to acquire Integer for $5.7B in all-cash deal at $127 per share

KKR has agreed to acquire Integer Holdings Corporation, a medical device contract development and manufacturing organisation, in an all-cash transaction valued at approximately $5.7 billion. Integer stockholders will receive $127 per share, representing a 51.8% premium to the company's closing share price on 29 April 2026. The acquisition follows a comprehensive strategic review announced by Integer in April 2026. The Integer Board unanimously approved the agreement and recommends stockholder approval. KKR plans to invest in Integer's capacity, technology, innovation, and talent. The firm also intends to establish a broad-based employee ownership programme following the transaction's close, consistent with its approach across portfolio companies. The transaction is expected to close by year-end, subject to stockholder approval and regulatory clearances. Upon completion, Integer will become privately held and delist from the New York Stock Exchange.

Yahoo Finance
Aug 3rd, 2026
Integer Holdings beats Q2 expectations with $464M revenue and $1.60 earnings per share

Integer Holdings Corp. reported second-quarter net income of $23.6 million, or 69 cents per share. Adjusted earnings came to $1.60 per share, exceeding Wall Street expectations of $1.38 per share. The Plano, Texas-based medical device outsource manufacturer posted revenue of $464.1 million for the period, also beating analyst forecasts of $452.5 million. The results surpassed predictions from five analysts surveyed by Zacks Investment Research on both earnings and revenue metrics.

Financial Modeling Prep
Aug 3rd, 2026
KKR & Co Inc (NYSE: KKR) Acquires Integer Holdings Corporation (NYSE: ITGR): key insights into the medical device acquisition.

KKR & Co Inc (NYSE: KKR) Acquires Integer Holdings Corporation (NYSE: ITGR): key insights into the medical device acquisition. Aug 03, 2026 Market News FMPKKR & Co Inc (NYSE: KKR) Acquires Integer Holdings Corporation (NYSE: ITGR):... * Integer Holdings Corporation (NYSE: ITGR) is being acquired by KKR (NYSE: KKR) for approximately $5.70 billion at $127.00 per share. * The acquisition price represents a 51.80% premium over Integer's closing price on April 29, 2026. * An investor rights law firm, Halper Sadeh LLC, is investigating the acquisition to ensure a fair price for shareholders and compliance with federal securities laws. Integer Holdings Corporation is a leading medical-device outsourcing company. It helps other companies develop and manufacture medical devices. On August 3, 2026, global investment firm KKR announced it will acquire Integer in a deal valued at an enterprise value of approximately $5.70 billion. An analyst at Truist Financial (NYSE: TFC) set a new price target for Integer at $127.00. This price target directly matches the $127.00 per share all-cash offer made by KKR for the acquisition. The acquisition follows a strategic review process conducted by Integer's board of directors. The analyst also downgraded the stock to a "Hold" rating. A "Hold" rating suggests that the stock's price is not expected to move much. This is common after an acquisition announcement, as the stock price tends to stay close to the agreed-upon purchase price until the deal is finalized. The $127.00 per share offer is a 51.80% premium over Integer's closing price on April 29, 2026. It is also a 28.80% premium to the 30-day volume-weighted average price (VWAP) as of July 31, 2026. VWAP is the average price a stock has traded at over a period, adjusted for trading volume. Despite the premium, an investor rights law firm, Halper Sadeh LLC, is investigating the sale. As highlighted by Business Wire, the firm is looking into whether Integer's board secured a fair price for its shareholders and followed federal securities laws during the process. Market news and analyst rating coverage Rayan Ahmad covers market news, analyst rating changes, and company developments for the FMP blog. His work focuses on summarizing price-target updates, earnings results, and broker actions into accessible, data-backed market updates. Financial data for every need. Real-time quotes and 30+ years of historical data, including prices, fundamentals, and insider transactions - all accessible via API. Stock Screener 2017-2026 (C) FMP